FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to oncology and can be used to predict risk of metastasis in lymphatic duplex synchronous invasive carcinoma of nonspecific type mammary glands. Method comprises: histological examination of both mammary glands, in which determination of infiltrative component tissue growth, where number of different types of structures from 1 to 5, among which are additionally alveolar, trabecular, solid structure and discrete group of tumour cells. In presence of structures of any type in infiltrative component tumour said index is estimated as 1 point, in presence of two different types of structures-2 points and so on, then availability or absence in infiltrative component discrete groups of tumour cells, no index is estimated as 1, and if in 2 points, also, intensity of inflammatory infiltration of tumour stroma, without it or presence of mild inflammatory infiltration stroma index is estimated as 1 point at moderate in 2 points, if sharply expressed infiltration stroma index is appraised as 3 points, also tumour stroma hyalinosis is assessed at absence or presence of weakly expressed hyalinosis stroma index is estimated as 1 point, moderately expressed hyalinosis in 2 points, if sharply expressed hyalinosis stroma in 3 points. Further, value of regression equation Y is calculated using a formula, which is used in claim to determine value of probability of developing lymphogenic metastases P. P > 50 % shows high, while P < 50 % shows a low risk of developing lymphogenic metastases. Sensitivity of method was 100 %, specificity was 83 %.
EFFECT: invention provides improved accuracy and information value of method.
1 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
METHOD FOR PREDICTION OF HAEMATOGENOUS METASTASIS IN TRIPLE NEGATIVE INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2558863C1 |
METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANIED BY INVASIVE NONSPECIFIC TRIPLE-NEGATIVE BREAST CANCER | 2014 |
|
RU2558860C1 |
METHOD FOR PREDICTING RISK OF LYMPHATIC CANCER SPREAD IN BREAST CANCER BASED ON YKL-39 PROTEIN GENE EXPRESSION | 2016 |
|
RU2632115C1 |
METHOD FOR PREDICTING LYMPHATIC CANCER SPREAD IN PANCREATIC DUCTUAL ADENOCARCINOMA | 2017 |
|
RU2648442C1 |
METHOD FOR PREDICTING LYMPHOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND | 2016 |
|
RU2659938C2 |
METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANYING NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2566732C1 |
METHOD FOR PREDICTION OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH THREE-TIMES NEGATIVE MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2623118C1 |
METHOD FOR PREDICTION OF DEGREE OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LUMINAL MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2632112C1 |
METHOD OF PREDICTING HEMATOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND BASED ON DETERMINATION OF DIFFERENT POPULATIONS OF CIRCULATING TUMOR CELLS IN BLOOD BEFORE TREATMENT | 2018 |
|
RU2678202C1 |
Authors
Dates
2016-03-27—Published
2015-02-03—Filed